Hiroshi Sunaga, John J Savarese, Jeff D McGilvra, Paul M Heerdt, Matthew R Belmont, Scott G Van Ornum, Matthew T Murrell, Jaideep K Malhotra, Peter M Savard, Erin Jeannotte, Bryce J Petty, Erica Allen, Gilbert W Carnathan
BACKGROUND: CW002, a novel nondepolarizing neuromuscular blocking agent of intermediate duration, is degraded in vitro by L-cysteine; CW002-induced neuromuscular blockade (NMB) is antagonized in vivo by exogenous L-cysteine. Further, Institutional Animal Care and Use Committee-approved studies of safety and efficacy in eight anesthetized monkeys and six cats are described. METHODS: Mean arterial pressure, heart rate, twitch, and train-of-four were recorded; estimated dose producing 95% twitch inhibition (ED95) for NMB and twitch recovery intervals from 5 to 95% of baseline were derived...
October 2016: Anesthesiology